CERK might contribute to inflammatory pain; Comments on Yu WL, Sun. Y (2015). CERK inhibition might be a good potential therapeutic target for diseases. Br J Pharmacol 172: 2165

Br J Pharmacol. 2016 Apr;173(7):1248-9. doi: 10.1111/bph.13443.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Apoptosis / drug effects*
  • Benzothiazoles / pharmacology*
  • Breast Neoplasms*
  • Bridged-Ring Compounds / pharmacology*
  • Cell Proliferation / drug effects*
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Lung Neoplasms*
  • M Phase Cell Cycle Checkpoints / drug effects*
  • Phosphotransferases (Alcohol Group Acceptor) / antagonists & inhibitors*
  • Tumor Stem Cell Assay*

Substances

  • Benzothiazoles
  • Bridged-Ring Compounds
  • Enzyme Inhibitors
  • Phosphotransferases (Alcohol Group Acceptor)